Integrated Proteins has accepted the resignation of Ms. Shivangi Paliwal from her positions as Company Secretary and Compliance Officer, effective July 27, 2026. The Board of Directors approved the resignation during a meeting held on July 27, 2026, at the company’s registered office in Jamnagar, Gujarat. Ms. Paliwal cited personal reasons for her departure, with no other material reasons disclosed in the filing.

The resignation was processed in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company submitted the disclosure to BSE Limited on July 27, 2026, referencing SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026. Ms. Paliwal was relieved from all official responsibilities and statutory positions at the closing business hours of July 27, 2026.

Resignation Details

Ms. Paliwal, who held membership number A80556, tendered her resignation via a letter dated July 27, 2026. The letter confirmed her exit from the role of Key Managerial Personnel and all other statutory or designated positions within the company. She expressed gratitude to the Board of Directors and colleagues for their support during her tenure.

Board Meeting Proceedings

The Board Meeting commenced at 17:00 HRS (IST) and concluded at 17:30 HRS (IST) on July 27, 2026. Hiren Dhirajlal Shah, Director (DIN: 09842161), signed the disclosure on behalf of Integrated Proteins Limited. The company is required to submit the necessary forms to the Registrar of Companies to formalize the change in key managerial personnel.

What This Means for Governance

The departure of the Company Secretary and Compliance Officer creates an immediate vacancy in a critical governance role responsible for regulatory compliance and corporate secretarial matters. Investors should monitor subsequent filings for the appointment of a successor to ensure continuity in compliance oversight.

Integrated Proteins has consolidated its leadership structure by approving the re-designation of Hiren Dhirajlal Shah as Chairman and Managing Director (CMD). The Board of Directors sanctioned the change during a meeting held on July 24, 2026, at the company’s registered office in Jamnagar, Gujarat. This strategic shift elevates Shah from his previous role as Additional Executive Director, signaling a focused approach to corporate governance and executive oversight for the listed protein products manufacturer. The appointment is subject to ratification by shareholders at an Extra-Ordinary General Meeting (EGM).

The Board scheduled the EGM for August 20, 2026, to be conducted via Video Conferencing or Other Audio Visual Means (OAVM). Shareholders holding shares as of the cut-off date of August 13, 2026, will be eligible to vote. The e-voting window opens on August 17, 2026, at 9:00 AM and closes on August 19, 2026, at 5:00 PM. Mrs. Ankita Tejas Shah, a Practicing Company Secretary (Membership No: A43289), has been appointed as the scrutinizer for the e-voting process.

Shah’s tenure as CMD will span five years, commencing on July 24, 2026, and concluding on July 23, 2031. The Board’s decision aligns with Sections 196, 197, and 203 of the Companies Act, 2013, read with Schedule V, and the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014. The filing confirms that Shah is not debarred from holding directorial office by the Securities and Exchange Board of India (SEBI) or any other regulatory authority.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026. The company filed the details with BSE Limited, where it is listed under Scrip Code 519606.

Key Details of the Appointment

Leadership Profile

Hiren Dhirajlal Shah brings a multidisciplinary background to the top leadership role. He holds a Bachelor of Computer Applications (BCA) and a Bachelor of Laws (LL.B.) degree from Saurashtra University. His professional expertise spans finance, accounting, business administration, and corporate management. Over the years, Shah has been actively involved in financial planning, regulatory compliance, and strategic decision-making, providing Integrated Proteins with experienced oversight in both operational and legal domains. The Board noted no relationship disclosures between directors regarding this appointment.